Related Experiment Video
Updated: Aug 6, 2026
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
Clinical and Microbiological Characteristics Associated with Treatment Outcomes Among Rifampicin-Resistant
Ivy Rukasha1,2, Kgothatso Ashley Rakgate1, Kabelo Gabriel Kaapu1
1Division of Medical Microbiology, Department of Pathology, School of Medicine, University of Limpopo, Polokwane, South Africa.
Background:
Drug-resistant tuberculosis (DR-TB) remains a major public health concern in South Africa, particularly in rural provinces such as Limpopo, where access to specialized care is limited. High HIV prevalence, population mobility, and constrained diagnostic capacity further complicate disease control. Province-specific data are essential to guide targeted interventions; however, factors associated with treatment outcomes in rural settings remain poorly characterized.
Methods:
A retrospective cohort study was conducted using routinely collected laboratory and programmatic data. All laboratory-confirmed DR-TB cases recorded in Limpopo Province between 2023 and 2025 were included. Microbiological data were obtained from the National Health Laboratory Service, while demographic, clinical, and treatment outcome data were extracted from the Electronic Drug-Resistant Tuberculosis Register. Descriptive statistics summarized patient characteristics. Associations with treatment outcomes were assessed using chi-square tests and multivariable logistic regression. Kaplan-Meier analysis compared survival by HIV status.
Results:
A total of 86 RR-TB patients were included. Most were aged 25-44 years (65.1%), with males comprising 70.9%, and 55.8% were HIV co-infected. Favourable treatment outcomes were observed in 62 (71.4%) patients, while 12 (14.3%) experienced unfavourable outcomes and 12 (14.3%) remained on treatment. In multivariable analysis, younger age (15-24 years) (AOR = 9.97, 95% CI: 1.48-67.33) and smear-negative status (AOR = 39.62, 95% CI: 3.33-471.83) were independently associated with unfavourable outcomes, whereas HIV status was not significant after adjustment. Kaplan-Meier analysis showed poorer survival among HIV-positive patients (log-rank p = 0.002), although this was not retained in the adjusted model.
Conclusion:
DR-TB in Limpopo is characterized by a high burden of TB-HIV co-infection and rifampicin resistance. Clinical factors, rather than resistance patterns, were key determinants of unfavourable outcomes. Strengthening integrated TB-HIV services, improving early diagnosis, and expanding drug susceptibility testing are critical to improving outcomes.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:25Clinical Significance of Antibiotic Resistance
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
01:25Rapid Identification of Pathogens
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...